Skip to main content
H.R. 2550 118th Congress House

Special Diabetes Program Reauthorization Act of 2023

Official title: To extend funding for Special Diabetes Programs for Type I diabetes.

Introduced: April 10, 2023 Introduced by: Diana DeGette Democratic · Colorado See on congress.gov
Health
Sign in to write a letter

Free account. One morning email at most, only on days something moved. Already have one? Sign in.

This bill died when the 118th Congress ended
It never became law before the 118th Congress (2023–2024) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 21, 2023
Referred to the Subcommittee on Health.
Apr 10, 2023
Introduced in House
Apr 10, 2023
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action April 21, 2023

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Special Diabetes Program Reauthorization Act of 2023

This bill extends funding through FY2028 for a program carried out by the National Institute of Diabetes and Digestive and Kidney Diseases that supports research on the prevention and cure of type 1 diabetes.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
 Lobbying activity 5

Registered lobbyists who named this bill in their disclosure filings. Source: federal Lobbying Disclosure Act filings.

  • MCCARTHY ADVANCED CONSULTING LLC
    for AMERICAN FEDERATION OF GOVERNMENT EMPLOYEES · District of Columbia · 3rd Quarter 2026 (July 1 - Sep 30)
  • VENABLE LLP
    for THE DIATRIBE FOUNDATION · California · 4th Quarter 2025 (Oct 1 - Dec 31)
  • VENABLE LLP
    for THE DIATRIBE FOUNDATION · California · 3rd Quarter 2025 (July 1 - Sep 30)
  • VENABLE LLP
    for THE DIATRIBE FOUNDATION · California · 2nd Quarter 2025 (Apr 1 - June 30)
  • VENABLE LLP
    for THE DIATRIBE FOUNDATION · California · 1st Quarter 2025 (Jan 1 - Mar 31)

Bodies those filers lobbied

A filing lists the bills it worked on and the parts of government it contacted in separate sections, so these are the bodies those filers named anywhere in the filing, not a per-bill breakdown.

 Cosponsors 8
All 8 Democratic 5 Republican 2
D
Leger Fernandez, Teresa
New Mexico · Sep 12, 2023
 D
Tlaib, Rashida
Michigan · Aug 29, 2023
 D
Doggett, Lloyd
Texas · Jun 21, 2023
Pascrell, Bill
· May 11, 2023
 D
Castor, Kathy
Florida · May 10, 2023
 D
Schrier, Kim
Washington · May 10, 2023
 R
Cole, Tom
Oklahoma · Apr 18, 2023
 R
Bilirakis, Gus M.
Florida · Apr 10, 2023
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2550: Special Diabetes Program Reauthorization Act of 2023. 118th Congress. Open America. https://openamerica.io/bill/118-HR-2550/
MLA
"H.R. 2550: Special Diabetes Program Reauthorization Act of 2023." 118th Congress, 2026, Open America, https://openamerica.io/bill/118-HR-2550/.
Bluebook (legal)
H.R. 2550, 118th Cong. (2026), https://openamerica.io/bill/118-HR-2550/.
Markdown link
[H.R. 2550: Special Diabetes Program Reauthorization Act of 2023](https://openamerica.io/bill/118-HR-2550/)
Report a problem